IO Biotech, Inc. (IOBT) financial statements (2022 and earlier)

Company profile

Business Address OLE MAALOES VEH 3
COPENHAGEN, 2200
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments211,531
Cash and cash equivalents211,531
Receivables1,250
Prepaid expense3,346
Other undisclosed current assets5,611
Total current assets:221,738
Noncurrent Assets
Restricted cash and investments268
Other noncurrent assets282
Total noncurrent assets:550
TOTAL ASSETS:222,288
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,444
Accounts payable3,928
Accrued liabilities1,489
Employee-related liabilities1,027
Other undisclosed current liabilities3,861
Total current liabilities:10,305
Noncurrent Liabilities
Liabilities, other than long-term debt59
Other liabilities59
Total noncurrent liabilities:59
Total liabilities:10,364
Stockholders' equity
Stockholders' equity attributable to parent211,924
Common stock29
Additional paid in capital319,665
Accumulated other comprehensive loss(1,489)
Accumulated deficit(106,281)
Total stockholders' equity:211,924
TOTAL LIABILITIES AND EQUITY:222,288

Income statement (P&L) ($ in thousands)

12/31/2021
Operating expenses(41,234)
Operating loss:(41,234)
Nonoperating expense(26,577)
Interest and debt expense(361)
Loss from continuing operations before equity method investments, income taxes:(68,172)
Other undisclosed income from continuing operations before income taxes361
Loss from continuing operations before income taxes:(67,811)
Income tax expense(68)
Net loss attributable to parent:(67,879)
Preferred stock dividends and other adjustments(7,108)
Net loss available to common stockholders, diluted:(74,987)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(67,879)
Comprehensive loss:(67,879)
Other undisclosed comprehensive loss, net of tax, attributable to parent(3,450)
Comprehensive loss, net of tax, attributable to parent:(71,329)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: